title: Comorbidity in adults with epilepsy--United States, 2010.
abstract: Epilepsy, a spectrum disorder characterized by recurring seizures, affects approximately 2.3 million U.S. adults. Epilepsy poses challenges because of uncontrolled seizures, treatment complexity, social disadvantages (e.g., unemployment), and stigma. Persons with epilepsy are at increased risk for early mortality and for comorbidities that can complicate epilepsy management, increase health-care costs, and shorten the lifespan. Numerous studies have described higher rates of psychiatric comorbidity (e.g., depression and anxiety) in persons with epilepsy. However, fewer studies have examined nonpsychiatric comorbidity in a nationally representative U.S. sample of adults with epilepsy. To assess the prevalence of nonpsychiatric comorbidities, CDC analyzed data from the 2010 National Health Interview Survey (NHIS). Adults with epilepsy had a higher prevalence of cardiovascular, respiratory, some inflammatory, and other disorders (e.g., headache, migraine, and various other types of pain) than adults without epilepsy. Public health agencies can work with health-care providers, the Epilepsy Foundation, and other partners to ensure that adults with epilepsy have access to health promotion resources and chronic disease self-management programs.
mesh_terms: D000328:Adult; D002318:Cardiovascular Diseases / Q000453:epidemiology; D002487:Centers for Disease Control and Prevention, U.S.; D015897:Comorbidity; D003430:Cross-Sectional Studies; D004827:Epilepsy / Q000453:epidemiology*; D006261:Headache / Q000453:epidemiology; D006306:Health Surveys; D006801:Humans; D007249:Inflammation / Q000453:epidemiology; D008881:Migraine Disorders / Q000453:epidemiology; D010146:Pain / Q000453:epidemiology; D012140:Respiratory Tract Diseases / Q000453:epidemiology; D014481:United States / Q000453:epidemiology